Garvan Institute and Illumina collaborate to transform the treatment of complex diseases
Illumina, a global genomics and human health company, has partnered with the Garvan Institute of Medical Research’s TenK10K project to help transform the treatment of complex diseases, starting with autoimmune diseases, with a joint investment of $27 million Australians The Garvan Institute plans to map 50 million human cells from 10,000 people to identify unique … Read more